Zevaquenabant ((S)-MRI-1867) is a peripherally restricted antagonist of the cannabinoid CB1 receptor and inducible nitric oxide synthase (iNOS). This compound has demonstrated potential in ameliorating obesity-induced chronic kidney disease (CKD), making it useful for research applications focused on metabolic disorders and renal pathologies. Its oral bioavailability enhances its utility in preclinical studies aimed at evaluating therapeutic strategies for obesity-related complications.
Zevaquenabant ((S)-MRI-1867) is a peripherally restricted antagonist of the cannabinoid CB1 receptor and inducible nitric oxide synthase (iNOS). This compound has demonstrated potential in ameliorating obesity-induced chronic kidney disease (CKD), making it useful for research applications focused on metabolic disorders and renal pathologies. Its oral bioavailability enhances its utility in preclinical studies aimed at evaluating therapeutic strategies for obesity-related complications.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
